1. Home
  2. GTBP vs RBNE Comparison

GTBP vs RBNE Comparison

Compare GTBP & RBNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • RBNE
  • Stock Information
  • Founded
  • GTBP 1965
  • RBNE 2024
  • Country
  • GTBP United States
  • RBNE Cyprus
  • Employees
  • GTBP N/A
  • RBNE N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • RBNE Marine Transportation
  • Sector
  • GTBP Health Care
  • RBNE Consumer Discretionary
  • Exchange
  • GTBP Nasdaq
  • RBNE Nasdaq
  • Market Cap
  • GTBP 5.5M
  • RBNE 6.6M
  • IPO Year
  • GTBP N/A
  • RBNE N/A
  • Fundamental
  • Price
  • GTBP $2.68
  • RBNE $2.75
  • Analyst Decision
  • GTBP Strong Buy
  • RBNE
  • Analyst Count
  • GTBP 1
  • RBNE 0
  • Target Price
  • GTBP $11.00
  • RBNE N/A
  • AVG Volume (30 Days)
  • GTBP 86.7K
  • RBNE 15.3K
  • Earning Date
  • GTBP 05-15-2025
  • RBNE 06-13-2025
  • Dividend Yield
  • GTBP N/A
  • RBNE N/A
  • EPS Growth
  • GTBP N/A
  • RBNE N/A
  • EPS
  • GTBP N/A
  • RBNE N/A
  • Revenue
  • GTBP N/A
  • RBNE N/A
  • Revenue This Year
  • GTBP N/A
  • RBNE N/A
  • Revenue Next Year
  • GTBP N/A
  • RBNE N/A
  • P/E Ratio
  • GTBP N/A
  • RBNE N/A
  • Revenue Growth
  • GTBP N/A
  • RBNE N/A
  • 52 Week Low
  • GTBP $1.72
  • RBNE $2.38
  • 52 Week High
  • GTBP $4.10
  • RBNE $6.53
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 56.17
  • RBNE N/A
  • Support Level
  • GTBP $2.56
  • RBNE N/A
  • Resistance Level
  • GTBP $2.82
  • RBNE N/A
  • Average True Range (ATR)
  • GTBP 0.30
  • RBNE 0.00
  • MACD
  • GTBP 0.01
  • RBNE 0.00
  • Stochastic Oscillator
  • GTBP 65.12
  • RBNE 0.00

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About RBNE Robin Energy Ltd. Common Stock

Robin Energy Ltd operates a tanker vessel that engages in the transportation of refined petroleum products using its Handysize product tanker.

Share on Social Networks: